Claudio Realini
Impact in
- Oncology top 5%
- Peptidase Inhibition and Analysis
- PARP inhibition in cancer therapy
- Cell Biology top 5%
- Endoplasmic Reticulum Stress and Disease
Papers in
-
- Ubiquitin and proteasome pathways 16
- DNA Repair Mechanisms 5
- Glycosylation and Glycoproteins Research 5
- Cancer therapeutics and mechanisms 4
- Oncology 13
- Peptidase Inhibition and Analysis 7
- PARP inhibition in cancer therapy 5
- Co-authors
- Martin Rechsteiner (16 shared papers)Felix R. Althaus (6 shared papers)Vicença Ustrell (3 shared papers)Christopher P. Hill (5 shared papers)Phyllis L. Panzeter (4 shared papers)Scott W. Rogers (1 shared paper)Steven C. Johnston (4 shared papers)G Pratt (2 shared papers)
- Journals
- Journal of Biological Chemistry (5 papers)Biochemistry (2 papers)FEBS Letters (2 papers)Biochemical Journal (2 papers)Protein Science (1 paper)
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Claudio Realini
26 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 75
- Oncology 692
- Cell Biology 415
- Molecular Biology 1.7k
- Immunology 486
- Parasitology 83
Countries citing papers authored by Claudio Realini
This map shows the geographic impact of Claudio Realini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Realini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Realini more than expected).
Fields of papers citing papers by Claudio Realini
This network shows the impact of papers produced by Claudio Realini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Realini. The network helps show where Claudio Realini may publish in the future.
Co-authors
The 25 scholars most cited alongside Claudio Realini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 215 | |
| 2 | 1999 | 193 | |
| 3 | 1994 | 148 | |
| 4 | 1994 | 147 | |
| 5 | 1997 | 145 | |
| 6 | 1997 | 143 | |
| 7 | 1992 | 142 | |
| 8 | 1992 | 109 | |
| 9 | 1999 | 96 | |
| 10 | 2000 | 79 | |
| 11 | 1998 | 76 | |
| 12 | 1997 | 74 | |
| 13 | 2011 | 71 | |
| 14 | 1994 | 55 | |
| 15 | 2003 | 52 | |
| 16 | 1995 | 41 | |
| 17 | 1995 | 34 | |
| 18 | 1993 | 32 | |
| 19 | 1997 | 31 | |
| 20 | 1998 | 26 |
About Claudio Realini
Claudio Realini is a scholar working on Molecular Biology, Oncology, Immunology, Cell Biology and Genetics, having authored 26 papers that have together received 2.0k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (16 papers), Peptidase Inhibition and Analysis (7 papers), DNA Repair Mechanisms (5 papers), Glycosylation and Glycoproteins Research (5 papers), PARP inhibition in cancer therapy (5 papers), Genetics and Neurodevelopmental Disorders (4 papers), Endoplasmic Reticulum Stress and Disease (4 papers) and Cancer therapeutics and mechanisms (4 papers). The work is most often cited by research in Oncology (692 citations), Cell Biology (415 citations), Molecular Biology (1.7k citations), Immunology (486 citations) and Parasitology (83 citations). Claudio Realini has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Martin Rechsteiner, Felix R. Althaus, Vicença Ustrell, Christopher P. Hill, Phyllis L. Panzeter, Scott W. Rogers, Steven C. Johnston, G Pratt, Christopher C. Jensen and Zhiguo Zhang. Their work appears in journals such as Journal of Biological Chemistry, Biochemistry, FEBS Letters, Biochemical Journal and Protein Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.